Archive for the ‘adult stem cells’ Category

Adult Stem Cells Growing Corneal Tissue

Sunday, November 25th, 2012

Researchers from Australia and New Zealand are at the forefront of techniques using adult stem cells to grow corneal tissue suitable for corneal transplants.

The cornea is the clear outer lens on the front of the eye. Corneal transplants are required when the cornea is damaged in some way due to trauma or disease. “In Australia and New Zealand, at least 2000 people per year need corneal transplants. However, globally, millions of people go blind each year from corneal disease,” said Prof Charles McGhee, Professor of Ophthalmology, University of Auckland, and Director of the New Zealand National Eye Centre.

“There are three cell layers in the cornea and we can already grow all those cell types, so it won’t be long until we can grow them into a functional biological cornea,” said Prof McGhee. “Whether that’s the whole cornea, or whether it’s specific layers of the cornea – we’ll suit it to the needs of the person.”

“It’s not unreasonable that in 10 years we might have a biological cornea created in the laboratory and transplanted into the patient. That’s a realistic goal for the next decade.  And by that we mean we’ll use some kind of a matrix as a substitute for a cornea and then grow a person’s own cells – or donated cells – into that matrix.”

Prof McGhee is one of the key speakers at the Annual Scientific Congress of The Royal Australian and New Zealand College of Ophthalmologists – being held in Melbourne this week from 24-28 November.

“In Australia and New Zealand, we’ve already treated 40-50 people using adult stem cell transplants. In some cases it’s appropriate to just transfer individual cell groups we want. The aim is to be able to treat corneal diseases that aren’t treatable with full corneal transplants. It’s a real tipping point at the moment.”

“It is important to note this technique does not use ‘embryo’ stem cells, but adult stem cells. We can take bits of stem cells and re-program the cells to another purpose, to repair parts of the body – in this case, the cornea,” said Prof McGhee.

Other research presented at the RANZCO Congress:

It was estimated that 0.02% of children in Western Australia are living with a blinding eye condition. Only half of these children are currently registered with the state provider of support services.

There are very little accurate data available on the prevalence of blindness in children.

“Childhood blindness carries a high financial cost for the community as well as a high individual cost impacting normal motor, language and social development of the child. These factors are all compounded when the child enters the education system and adulthood,” said Dr Julie Crewe, Curtin Health Innovation Research Institute, Curtin University.

Reference: http://www.voxy.co.nz/health/adult-stem-cells-grow-your-own-corneal-implant/5/141497

Adult Stem Cell Pioneers win Nobel Prize

Saturday, October 13th, 2012

STOCKHOLM—Shinya Yamanaka of Japan and John Gurdon of Britain won the Nobel Prize on Monday for work in cell programming, a frontier that has nourished dreams of replacement tissue for people crippled by disease.

The two scientists found that adult cells (those that reside in our own bodies) can be transformed back to an infant state called stem cells, the key ingredient in the vision of regenerative medicine.

“Their findings have revolutionized our understanding of how cells and organisms develop,” the Nobel jury declared. “By reprogramming human cells, scientists have created new opportunities to study diseases and develop methods for diagnosis and therapy.”

Stem cells are precursor cells which differentiate into the various organs of the body.

“The discoveries of Gurdon and Yamanaka have shown that specialized cells can turn back the developmental clock under certain circumstances,” the committee said. “These discoveries have also provided new tools for scientists around the world and led to remarkable progress in many areas of medicine.”

Gurdon, 79, has served as a professor of cell biology at Cambridge University’s Magdalene College and is currently at the Gurdon Institute in Cambridge, which he founded. Yamanaka, born in 1962, worked at the Gladstone Institute in San Francisco and Nara Institute of Science and Technology in Japan.  They have made huge strides, with developments towards replacement tissue for victims of Alzheimer’s, Parkinson’s and other diseases.